Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
20.16
+0.23 (1.15%)
At close: Jan 16, 2026, 4:00 PM EST
20.46
+0.30 (1.51%)
After-hours: Jan 16, 2026, 7:19 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Immune-based Therapies
5.00M
Log In
Immune-based Therapies Growth
-90.00%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M
Log In
United States Growth
-90.00%
Log In